Kevin Patrick Lynch
Nessuna posizione attualmente
Patrimonio netto: - $ in data 31/03/2024
Storia della carriera di Kevin Patrick Lynch
Precedenti posizioni note di Kevin Patrick Lynch
Società | Posizione | Inizio | Fine |
---|---|---|---|
ANTENGENE CORPORATION LIMITED | Director/Board Member | 18/06/2021 | 16/12/2022 |
Chief Tech/Sci/R&D Officer | 25/03/2021 | 16/12/2022 | |
CELGENE | Corporate Officer/Principal | 01/01/2011 | 01/01/2019 |
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a private company based in Sydney, Australia. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Australia | 2 |
Cina | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ANTENGENE CORPORATION LIMITED | Health Technology |
Aziende private | 2 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a private company based in Sydney, Australia. | Health Technology |
- Borsa valori
- Insiders
- Kevin Patrick Lynch
- Esperienza